Mixed Epithelial and Stromal Tumor of the Kidney With Elevated Serum Level of Cancer Antigen 125

Mixed Epithelial and Stromal Tumor of the Kidney With Elevated Serum Level of Cancer Antigen 125

Mixed epithelial and stromal tumor of the kidney is a newly categorized lesion, with few reported cases. We report a rare case of a 45-year-old woman with a palpable abdominal mass and elevated serum level of serum cancer antigen 125, who was not receiving hormones or contraceptive agents. Abdominal...

Full description

Bibliographic Details
Main Authors:	Chih-Hsin Liu, Chia-Cheng Yu, Chao-Ren Chang, Tony T. Wu, Jong-Khing Huang
Format:	Article
Language:	English
Published:	Elsevier 2011-02-01
Series:	Journal of the Formosan Medical Association
Subjects:	CA-125 kidney tumor mixed epithelial and stromal tumor ovarian-type stroma
Online Access:	http://www.sciencedirect.com/science/article/pii/S092966461160020X

Similar Items

Meigs’ syndrome with elevated serum cancer antigen 125 levels in a case of ovarian sclerosing stromal tumor
by: Jia-Hung Liou, et al.
Published: (2011-06-01)

Meigs' syndrome with elevated CA 125: case report
by: Sabas Carlos Vieira, et al.

Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
by: Ji Hui Choi, et al.
Published: (2018-05-01)

"CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?"
by: M. Modarres-Gilani, et al.
Published: (2004-12-01)

"CAN PREOPERATIVE CA-125 PREDICT RESECTABILITY OF TUMOR IN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CARCINOMA?"
by: M. Modarres-Gilani, et al.
Published: (2004-11-01)

Correlation of Cytohistlogical Expression and Serum Level of Ca125 in Ovarian Neoplasm
by: Chhanda Das, et al.
Published: (2014-03-01)

Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125
by: Szu-Ting Yang, et al.
Published: (2023-11-01)

Mixed epithelial and stromal tumor of the kidney
by: Shuo Zheng, et al.
Published: (2013-05-01)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
by: G. N. A. Winarno, et al.
Published: (2020-07-01)

Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies
by: Lars Schröder, et al.
Published: (2023-11-01)

The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
by: Zheng Li-e, et al.
Published: (2016-01-01)

Mixed epithelial and stromal tumor of the kidney
by: Raphael Hart Lyngdoh, et al.
Published: (2013-01-01)

CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01)

CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
by: Wang Fang, et al.
Published: (2013-02-01)

Prognostic significance of serum CA125 in the overall management for patients with gastrointestinal stromal tumors
by: Chao Sui, et al.
Published: (2023-01-01)

Histomorphological evaluation of desmoplastic tumor stroma in malignant ovarian surface epithelial tumors
by: Sana Ahuja, et al.
Published: (2023-01-01)

Mixed epithelial stromal tumor of the kidney
by: Hariprasada D Rao, et al.
Published: (2011-01-01)

CA 125: History, Current Status, and Future Prospects
by: Robert C., Jr Bast, et al.
Published: (2020-12-01)

Mixed epithelial and stromal tumor of the kidney treated with minimally invasive surgery
by: Can Aykanat, et al.
Published: (2020-01-01)

Mixed epithelial and stromal tumor of the kidney with long-term imaging follow-up
by: Kensuke Domae, MD, et al.
Published: (2023-09-01)

The Effect of Delayed Chemotherapy on the Decrease of CA125 in Epithelial Ovarian Cancer During Coronavirus Disease Pandemic in 2020
by: Yi Q, et al.
Published: (2021-01-01)

Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
by: Guo Junhong, et al.
Published: (2017-05-01)

The value of ultrasonography combined with carbohydrate antigen 125 and 19-9 detection in the diagnosis of borderline ovarian tumors and prediction of recurrence
by: Lina Niu, et al.
Published: (2023-01-01)

Evaluating Specivity, Sensitivity, Positive and Negative Predictive Values of CA125 for Diagnosing Ovarian Cancer
by: Elahe Fini, et al.
Published: (2021-08-01)

Evaluating Specivity, Sensitivity, Positive and Negative Predictive Values of CA125 for Diagnosing Ovarian Cancer
by: Elahe Fini, et al.
Published: (2021-08-01)

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
by: Jie-Ping Chen, et al.
Published: (2019-07-01)

The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma
by: Joseph Menczer, et al.
Published: (2015-01-01)

Diagnostic Added-Value of Serum CA-125 on the IOTA Simple Rules and Derivation of Practical Combined Prediction Models (IOTA SR X CA-125)
by: Phichayut Phinyo, et al.
Published: (2021-01-01)

Over Kanserli Hastalarda CA-125 ve Seruloplazmin Düzeyleri
by: Mangala HEGDE, et al.
Published: (2015-09-01)

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial
by: Michel Fabbro, et al.
Published: (2024-01-01)

GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer
by: Dan Zhao, et al.
Published: (2018-03-01)

Relationship between Serum Tumor Markers, CA-125, CEA, CA19-9, LDH, and βHCG with Histopathology and Age in Women with Ovarian Tumors
by: Nilajkumar D Bagde, et al.
Published: (2020-12-01)

Enucleation/partial nephrectomy for large mixed epithelial stromal tumor and herniating into the pelvicalyceal system
by: Mohamed H Kamel, et al.
Published: (2014-01-01)

Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review
by: Puck E. Brons, et al.
Published: (2022-11-01)

Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer
by: Lu Qin, et al.
Published: (2018-06-01)

The role of Wilm’s Tumor1 immunohistochemical marker in surface epithelial ovarian tumors
by: Muna I. AL Hafedh, et al.
Published: (2015-07-01)

Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer
by: Rachna Anand, et al.
Published: (2011-03-01)

Two case reports of mixed epithelial and stromal renal tumor of kidney in children and literature review analysis
by: Xia Wei, et al.
Published: (2023-01-01)

Mixed epithelial and stromal tumor of the kidney extending to the proximal ureter in a 41-year-old female
by: Alanna M. Cruz Bendezú, et al.
Published: (2021-09-01)

Mixed Epithelial and Stromal Tumor Family of Kidney (Adult Cystic Nephroma, Mixed Epithelial and Stromal Tumor): Retrospective Clinicopathological Evaluation
by: Hale DEMIR, et al.
Published: (2022-09-01)